Protagenic Therapeutics Files 8-K
Ticker: PTIXW · Form: 8-K · Filed: Nov 5, 2024 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Nov 5, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $1.275 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: PTIX
TL;DR
Protagenic Therapeutics filed an 8-K on Nov 4, 2024, with financial and other event updates.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on November 4, 2024, reporting on several events. The filing includes information related to financial statements and exhibits, as well as other events and a Regulation FD disclosure. The company was formerly known as Atrinsic, Inc., NEW MOTION, INC., and MPLC, Inc.
Why It Matters
This 8-K filing provides updates on company events and financial information, which are crucial for investors to assess the company's current status and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting on events and exhibits, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- Atrinsic, Inc. (company) — Former Company Name
- NEW MOTION, INC. (company) — Former Company Name
- MPLC, Inc. (company) — Former Company Name
- November 4, 2024 (date) — Date of Earliest Event Reported
FAQ
What is the primary purpose of this 8-K filing for Protagenic Therapeutics, Inc.?
The 8-K filing serves as a current report for Protagenic Therapeutics, Inc., detailing Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits as of November 4, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on November 4, 2024.
What were Protagenic Therapeutics, Inc.'s previous names?
Protagenic Therapeutics, Inc. was formerly known as Atrinsic, Inc., NEW MOTION, INC., and MPLC, Inc.
What is the Standard Industrial Classification (SIC) code for Protagenic Therapeutics, Inc.?
The SIC code for Protagenic Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
In which state is Protagenic Therapeutics, Inc. incorporated?
Protagenic Therapeutics, Inc. is incorporated in Delaware (DE).
Filing Stats: 858 words · 3 min read · ~3 pages · Grade level 12.3 · Accepted 2024-11-05 07:39:41
Key Financial Figures
- $0.0001 — f the Company's common stock, par value $0.0001 per share ("Common Stock"), (b) series
- $1.275 m — from the Transaction were approximately $1.275 million, before deducting fees and other
Filing Documents
- form8-k.htm (8-K) — 51KB
- ex99-1.htm (EX-99.1) — 9KB
- 0001493152-24-043615.txt ( ) — 281KB
- ptix-20241104.xsd (EX-101.SCH) — 4KB
- ptix-20241104_def.xml (EX-101.DEF) — 29KB
- ptix-20241104_lab.xml (EX-101.LAB) — 36KB
- ptix-20241104_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTAGENIC THERAPEUTICS, INC. Date: November 5, 2024 By: /s/ Alexander K. Arrow Name: Alexander K. Arrow Title: Chief Financial Officer 3